Iliac vein stenosis or occlusion
Conditions
Interventions
single arm:Iliac vein stent implantation
Sponsors
Chinese PLA General Hospital,Fudan University, Zhongshan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. subjects aged 18-80 years; 2. CEAP clinical grade C >=3; 3. iliac vein stenosis >=50% or occlusion; 4. patients voluntarily sign informed consent and complete follow-up.
Exclusion criteria
Exclusion criteria: 1. subjects in pregnancy or lactation; 2. renal insufficiency; 3. subjects are allergic to contrast agents and anesthetics; 4. subjects are allergic to nitinol; 5. the life expectancy of cancer patients is less than 1 year; 6. the length of the stent is expected to exceed the length of the inguinal ligament; 7. both sides of iliac vein stents were required; 8. long term bedridden or wheelchair patients; 9. the target vessel of the subject has been implanted into the iliac vein stent; 10. subjects have anticoagulant contraindications or are unable to receive long-term new oral anticoagulant therapy; 11. the investigator judged that the subjects had poor compliance and could not complete the clinical trial; 12. subjects are participating in clinical trials of other drugs or medical devices and have not yet completed the primary end point of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patency rate of venous stent 12 months after operation; | — |
Countries
China
Contacts
Public ContactZhang Meng-Sha
Hangzhou Weiqiang Medical Technology Co., Ltd.
Outcome results
None listed